The Research and Development Team at MacroGenics is responsible for advancing the company’s pipeline of monoclonal antibody therapeutics through innovative research, product development, and clinical trial support. This multidisciplinary team collaborates on various aspects of drug discovery, from antibody engineering and bioprocessing to translational biology and regulatory compliance, ensuring that new therapies effectively target cancer and autoimmune diseases while meeting industry standards.